Cybin Closes Short-Lasting Overnight Public Offering With Top Issuance For $8.25M
Psychedelics biotech Cybin Inc. (NYSE: CYBN) closed its recently announced overnight marketed public offering with an aggregate of 24,264,706 units
Jamaica-Based Kaya Group Partners With Silo Wellness, Announce Share Exchange And Psychedelic Wellness Retreats
As of August 2, psychedelics and wellness company Silo Wellness (OTCQB: SILFF) and Jamaican NUGL Inc. (OTC Pink: NUGL) via the Kaya Group, are strategic partners offering a range o
COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And ‘Strong Progress Across The Business’
Psychedelics biotech COMPASS Pathways’ (NASDAQ: CMPS) consolidated unaudited financial results for the second quarter 2023, ended June 30 are as follows:
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs
Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances with that of classic drugs.
Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player
Optimi Completes Novel Extraction Process and Files U.S. Prov. Patent
Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
Clinical-stage psychedelics biotech Reunion Neuroscience (NASDAQ: REUN) and MPM BioImpact have completed their announced plan of arrangement for MPM&rsq
Awakn Life Sciences Becomes Pure R&D Biotech After Sale Of Norway Clinics
As part of its business restructuring process and following its London clinics busin
Jamaica Launches Organic Psilocybin Gummies & New Psychedelic Retreat: Rose Hill’s New Offer
Rose Hill, a Jamaica-based cultivator, supplier and exporter of premium psilocybin products and biomass to research partners and brands is now offering its first wellness retreat program under the name ONE Retreats.
PharmAla Files IP Protection For Novel MDXX Molecule: Viability As Autism Spectrum Treatment
Canadian biotech company PharmAla Biotech Holdings (OTC: PMBHF) has filed a patent covering composition of matter of Novel Chemical Entity (NCE) PharmAla-1.
Increased Production & Retail Sales For Magic Truffles: Red Light Holland Balances 2023 Financial Results
Ontario-based all-mushrooms producer Red Light Holland Corp. (OTCQB: TRUFF) filed its audited annual financial statements, plus management takes and analysis, for the financial years ended March 31, 2023 and 2022.
2023's Numbers: